Trip is mentioned thousands of times in articles in Google Scholar (click here) and in the last year over 300 times (click here). Most of these are systematic reviews and I found two new articles today, these were:
- Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: A systematic review of the literature
- Trauma center performance evaluation based on costs: A systematic review of cohort studies
Needless to say Trip was not alone and other databases mentioned in these SRs were:
Web of Science
What’s different about Trip? Size, only one paid employee (me and one day per week)!